Biogen: Clinical Trials & Research Profile
Biopharma Industry (Cambridge, MA) · Primary Focus: Neurology, Psychiatry, and Pain
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Cambridge, MA) |
| Primary Therapeutic Area | Neurology, Psychiatry, and Pain |
| Active Phase II & III Studies | 22 active (11 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 61 (47 with California sites) |
| Completed vs Early-Stopped Studies | 19 completed / 20 stopped (32.8% stop rate) |
| Median Closed Enrollment | 155 participants |
| FDA Drugs@FDA Original Approvals | 12 all-time (6 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 84.6% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Biogen across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk